{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:20:54Z","timestamp":1792264854920,"version":"4.4.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1093\/brain\/awh445","type":"journal-article","created":{"date-parts":[[2005,2,16]],"date-time":"2005-02-16T20:13:39Z","timestamp":1108584819000},"page":"1314-1322","source":"Crossref","is-referenced-by-count":930,"title":["Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system"],"prefix":"10.1093","volume":"128","author":[{"given":"Philippe","family":"Remy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"Doder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Turjanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,2,16]]},"reference":[{"key":"key\n\t\t\t\t20171011205149_B1","doi-asserted-by":"crossref","unstructured":"Arango V, Underwood MD, Mann JJ. Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol Psychiatry1996; 39: 112\u201320.","DOI":"10.1016\/0006-3223(95)00107-7"},{"key":"key\n\t\t\t\t20171011205149_B2","doi-asserted-by":"crossref","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry1961; 4: 561\u201371.","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"key\n\t\t\t\t20171011205149_B3","doi-asserted-by":"crossref","unstructured":"Bremner JD, Vythilingam M, Ng CK, Vermetten E, Nazeer A, Oren DA, et al. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. J Am Med Assoc2003; 289: 3125\u201334.","DOI":"10.1001\/jama.289.23.3125"},{"key":"key\n\t\t\t\t20171011205149_B4","unstructured":"Brown R, Jahanshahi M. Depression in Parkinson's disease: a psychosocial viewpoint. In: Weiner WJ, Lang AE, editors. Behavioral neurology of movement disorders. Vol. 65. New York: Raven Press; 1995. p. 61\u201384."},{"key":"key\n\t\t\t\t20171011205149_B5","doi-asserted-by":"crossref","unstructured":"Cabib S, Puglisi-Allegra S. Stress, depression and the mesolimbic dopamine system. Psychopharmacology (Berl)1996; 128: 331\u201342.","DOI":"10.1007\/s002130050142"},{"key":"key\n\t\t\t\t20171011205149_B6","doi-asserted-by":"crossref","unstructured":"Cantello R, Aguggia M, Gilli M, Delsedime M, Chiardo Cutin I, Riccio A, et al. Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the \u2018hedonic\u2019 dopamine synapse. J Neurol Neurosurg Psychiatry1989; 52: 724\u201331.","DOI":"10.1136\/jnnp.52.6.724"},{"key":"key\n\t\t\t\t20171011205149_B7","doi-asserted-by":"crossref","unstructured":"Carroll FI, Scheffel U, Dannals RF, Boja JW, Kuhar MJ. Development of imaging agents for the dopamine transporter. Med Res Rev1995; 15: 419\u201344.","DOI":"10.1002\/med.2610150503"},{"key":"key\n\t\t\t\t20171011205149_B8","doi-asserted-by":"crossref","unstructured":"Cummings JL, Masterman DL. Depression in patients with Parkinson's disease. Int J Geriatr Psychiatry1999; 14.","DOI":"10.1002\/(SICI)1099-1166(199909)14:9<711::AID-GPS4>3.0.CO;2-1"},{"key":"key\n\t\t\t\t20171011205149_B9","doi-asserted-by":"crossref","unstructured":"Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia2002; 40: 2257\u201367.","DOI":"10.1016\/S0028-3932(02)00108-2"},{"key":"key\n\t\t\t\t20171011205149_B10","doi-asserted-by":"crossref","unstructured":"David Johnson J. Noradrenergic control of cognition: global attenuation and an interrupt function. Med Hypotheses2003; 60: 689\u201392.","DOI":"10.1016\/S0306-9877(03)00021-5"},{"key":"key\n\t\t\t\t20171011205149_B11","doi-asserted-by":"crossref","unstructured":"Drevets WC. Functional neuroimaging studies of depression: the anatomy of melancholia. Annu Rev Med1998; 49: 341\u201361.","DOI":"10.1146\/annurev.med.49.1.341"},{"key":"key\n\t\t\t\t20171011205149_B12","doi-asserted-by":"crossref","unstructured":"Fallon JH, Koziell DA, Moore RY. Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J Comp Neurol1978; 180: 509\u201332.","DOI":"10.1002\/cne.901800308"},{"key":"key\n\t\t\t\t20171011205149_B13","doi-asserted-by":"crossref","unstructured":"Fudge JL, Emiliano AB. The extended amygdala and the dopamine system: another piece of the dopamine puzzle. J Neuropsychiatry Clin Neurosci2003; 15: 306\u201316.","DOI":"10.1176\/jnp.15.3.306"},{"key":"key\n\t\t\t\t20171011205149_B14","doi-asserted-by":"crossref","unstructured":"Gareri P, De Fazio P, De Sarro G. Neuropharmacology of depression in aging, and age-related changes. Aging Res Rev2002; 1: 113\u2013134.","DOI":"10.1016\/S0047-6374(01)00370-0"},{"key":"key\n\t\t\t\t20171011205149_B15","doi-asserted-by":"crossref","unstructured":"Gunn RN, Lammerstma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand\u2013receptor binding in PET using a simplified reference region model. Neuroimage1997; 6: 279\u2013287.","DOI":"10.1006\/nimg.1997.0303"},{"key":"key\n\t\t\t\t20171011205149_B16","doi-asserted-by":"crossref","unstructured":"Guttman M, Burkholder J, Kish SJ, Hussey D, Wilson A, DaSilva J, et al. [11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold. Neurology1997; 48: 1578\u201383.","DOI":"10.1212\/WNL.48.6.1578"},{"key":"key\n\t\t\t\t20171011205149_B17","doi-asserted-by":"crossref","unstructured":"Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RG, Howe PR, et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol1990; 27: 373\u201385.","DOI":"10.1002\/ana.410270405"},{"key":"key\n\t\t\t\t20171011205149_B18","doi-asserted-by":"crossref","unstructured":"Harding AJ, Stimson E, Henderson JM, Halliday GM. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain2002; 125: 2431\u201345.","DOI":"10.1093\/brain\/awf251"},{"key":"key\n\t\t\t\t20171011205149_B19","doi-asserted-by":"crossref","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry1992; 55: 181\u20134.","DOI":"10.1136\/jnnp.55.3.181"},{"key":"key\n\t\t\t\t20171011205149_B20","doi-asserted-by":"crossref","unstructured":"Kaasinen V, Nurmi E, Bergman J, Eskola O, Solin O, Sonninen P, et al. Personality traits and brain dopaminergic function in Parkinson's disease. Proc Natl Acad Sci USA2001; 98: 13272\u20137.","DOI":"10.1073\/pnas.231313198"},{"key":"key\n\t\t\t\t20171011205149_B21","doi-asserted-by":"crossref","unstructured":"Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med1988; 318: 876\u201380.","DOI":"10.1056\/NEJM198804073181402"},{"key":"key\n\t\t\t\t20171011205149_B22","doi-asserted-by":"crossref","unstructured":"Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, et al. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci1997; 17: 8451\u20138.","DOI":"10.1523\/JNEUROSCI.17-21-08451.1997"},{"key":"key\n\t\t\t\t20171011205149_B23","doi-asserted-by":"crossref","unstructured":"Laasonen-Balk T, Kuikka J, Viinamaki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J. Striatal dopamine transporter density in major depression. Psychopharmacology (Berl)1999; 144: 282\u20135.","DOI":"10.1007\/s002130051005"},{"key":"key\n\t\t\t\t20171011205149_B24","doi-asserted-by":"crossref","unstructured":"LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci2000; 23: 155\u201384.","DOI":"10.1146\/annurev.neuro.23.1.155"},{"key":"key\n\t\t\t\t20171011205149_B25","doi-asserted-by":"crossref","unstructured":"Mahieux F, Michelet D, Manifacier MJ, Boller F, Fermarian J, Guillard A. Mini-mental Parkinson first validation study of a new bedside test constructed for Parkinson's disease. Behav Neurol1995; 8: 15\u201322.","DOI":"10.1155\/1995\/304876"},{"key":"key\n\t\t\t\t20171011205149_B26","doi-asserted-by":"crossref","unstructured":"Maricle RA, Nutt JG, Valentine RJ, Carter JH. Dose\u2013response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study. Neurology1995; 45: 1757\u201360.","DOI":"10.1212\/WNL.45.9.1757"},{"key":"key\n\t\t\t\t20171011205149_B27","doi-asserted-by":"crossref","unstructured":"Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res1991; 38: 143\u201362.","DOI":"10.1016\/0165-1781(91)90040-V"},{"key":"key\n\t\t\t\t20171011205149_B28","doi-asserted-by":"crossref","unstructured":"Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol1990; 28: 57\u201364.","DOI":"10.1002\/ana.410280111"},{"key":"key\n\t\t\t\t20171011205149_B29","doi-asserted-by":"crossref","unstructured":"Mentis MJ, McIntosh AR, Perrine K, Dhawan V, Berlin B, Feigin A, et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry2002; 159: 746\u201354.","DOI":"10.1176\/appi.ajp.159.5.746"},{"key":"key\n\t\t\t\t20171011205149_B30","doi-asserted-by":"crossref","unstructured":"Metzger RR, Brown JM, Sandoval V, Rau KS, Elwan MA, Miller GW, et al. Inhibitory effect of reserpine on dopamine transporter function. Eur J Pharmacol2002; 456: 39\u201343.","DOI":"10.1016\/S0014-2999(02)02647-X"},{"key":"key\n\t\t\t\t20171011205149_B31","doi-asserted-by":"crossref","unstructured":"Meyer JH, Kruger S, Wilson AA, Christensen BK, Goulding VS, Schaffer A, et al. Lower dopamine transporter binding potential in striatum during depression. Neuroreport2001; 12: 4121\u20135.","DOI":"10.1097\/00001756-200112210-00052"},{"key":"key\n\t\t\t\t20171011205149_B32","doi-asserted-by":"crossref","unstructured":"Moore RY. Organization of midbrain dopamine systems and the pathophysiology of Parkinson's disease. Parkinsonism Relat Disord2003; 9 Suppl 2: S65\u201371.","DOI":"10.1016\/S1353-8020(03)00063-4"},{"key":"key\n\t\t\t\t20171011205149_B33","doi-asserted-by":"crossref","unstructured":"Nakano K. Neural circuits and topographic organization of the basal ganglia and related regions. Brain Dev2000; 22 Suppl 1: S5\u201316.","DOI":"10.1016\/S0387-7604(00)00139-X"},{"key":"key\n\t\t\t\t20171011205149_B34","doi-asserted-by":"crossref","unstructured":"Nicola SM, Malenka RC. Modulation of synaptic transmission by dopamine and norepinephrine in ventral but not dorsal striatum. J Neurophysiol1998; 79: 1768\u201376.","DOI":"10.1152\/jn.1998.79.4.1768"},{"key":"key\n\t\t\t\t20171011205149_B35","doi-asserted-by":"crossref","unstructured":"Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol2002; 67: 53\u201383.","DOI":"10.1016\/S0301-0082(02)00011-4"},{"key":"key\n\t\t\t\t20171011205149_B36","doi-asserted-by":"crossref","unstructured":"Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci1996; 16: 436\u201347.","DOI":"10.1523\/JNEUROSCI.16-02-00436.1996"},{"key":"key\n\t\t\t\t20171011205149_B37","doi-asserted-by":"crossref","unstructured":"Oke AF, Carver LA, Gouvion CM, Adams RN. Three-dimensional mapping of norepinephrine and serotonin in human thalamus. Brain Res1997; 763: 69\u201378.","DOI":"10.1016\/S0006-8993(97)00404-6"},{"key":"key\n\t\t\t\t20171011205149_B38","doi-asserted-by":"crossref","unstructured":"Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol1991; 50: 743\u201355.","DOI":"10.1097\/00005072-199111000-00006"},{"key":"key\n\t\t\t\t20171011205149_B39","doi-asserted-by":"crossref","unstructured":"Paus T, Petrides M, Evans AC, Meyer E. Role of the human anterior cingulate cortex in the control of oculomotor, manual, and speech responses: a positron emission tomography study. J Neurophysiol1993; 70: 453\u2013469.","DOI":"10.1152\/jn.1993.70.2.453"},{"key":"key\n\t\t\t\t20171011205149_B40","doi-asserted-by":"crossref","unstructured":"Rakshi JS, Uema T, Ito K, Bailey DL, Morrish PK, Ashburner J, et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease: a 3D [18F]Dopa-PET study. Brain1999; 122: 1637\u201350.","DOI":"10.1093\/brain\/122.9.1637"},{"key":"key\n\t\t\t\t20171011205149_B41","doi-asserted-by":"crossref","unstructured":"Ressler KJ, Nemeroff CB. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry1999; 46: 1219\u201333.","DOI":"10.1016\/S0006-3223(99)00127-4"},{"key":"key\n\t\t\t\t20171011205149_B42","doi-asserted-by":"crossref","unstructured":"Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RS, Dolan RJ. Depression in Parkinson's disease. A positron emission study. Br J Psychiatry1994; 165: 333\u20139.","DOI":"10.1192\/bjp.165.3.333"},{"key":"key\n\t\t\t\t20171011205149_B43","doi-asserted-by":"crossref","unstructured":"Rodin G, Voshart K. Depression in the medically ill: an overview. Am J Psychiatry1986; 143: 696\u2013705.","DOI":"10.1176\/ajp.143.6.696"},{"key":"key\n\t\t\t\t20171011205149_B44","unstructured":"Spielberger C, Gorsuch RL, Lushene RE. Manual for the State Trait Inventory. Palo Alto (CA): Consulting Psychologists Press; 1970."},{"key":"key\n\t\t\t\t20171011205149_B45","doi-asserted-by":"crossref","unstructured":"Sullivan GM, Coplan JD, Kent JM, Gorman JM. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry1999; 46: 1205\u201318.","DOI":"10.1016\/S0006-3223(99)00246-2"},{"key":"key\n\t\t\t\t20171011205149_B46","unstructured":"Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme; 1988."},{"key":"key\n\t\t\t\t20171011205149_B47","doi-asserted-by":"crossref","unstructured":"Tom T, Cummings JL. Depression in Parkinson's disease. Pharmacological characteristics and treatment. Drugs Aging1998; 12: 55\u201374.","DOI":"10.2165\/00002512-199812010-00006"},{"key":"key\n\t\t\t\t20171011205149_B48","doi-asserted-by":"crossref","unstructured":"Williams SM, Goldman-Rakic PS. Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. Cereb Cortex1993; 3: 199\u2013222.","DOI":"10.1093\/cercor\/3.3.199"},{"key":"key\n\t\t\t\t20171011205149_B49","doi-asserted-by":"crossref","unstructured":"Wilson AA, DaSilva JN, Houle S. In vivo evaluation of [11C]- and [18F]-labelled cocaine analogues as potential dopamine transporter ligands for positron emission tomography. Nucl Med Biol1996; 23: 141\u20136.","DOI":"10.1016\/0969-8051(95)02044-6"},{"key":"key\n\t\t\t\t20171011205149_B50","doi-asserted-by":"crossref","unstructured":"Woods RP, Mazziotta JC, Cherry SR. MRI\u2013PET registration with automated algorithm. J Comput Assist Tomogr1993; 17: 536\u201346.","DOI":"10.1097\/00004728-199307000-00004"},{"key":"key\n\t\t\t\t20171011205149_B51","doi-asserted-by":"crossref","unstructured":"Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp1996; 4: 58\u201373.","DOI":"10.1002\/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O"},{"key":"key\n\t\t\t\t20171011205149_B52","doi-asserted-by":"crossref","unstructured":"Zweig RM, Cardillo JE, Cohen M, Giere S, Hedreen JC. The locus ceruleus and dementia in Parkinson's disease. Neurology1993; 43: 986\u201391.","DOI":"10.1212\/WNL.43.5.986"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/128\/6\/1314\/1190154\/awh445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T07:27:44Z","timestamp":1548574064000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/brain\/article\/128\/6\/1314\/431876\/Depression-in-Parkinsons-disease-loss-of-dopamine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,16]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,2,16]]},"published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awh445","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,6]]},"published":{"date-parts":[[2005,2,16]]}}}